Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
NCT06510998

Isometric Resistance Exercise for Hypertension

Led by Chinese University of Hong Kong · Updated on 2025-12-29

390

Participants Needed

2

Research Sites

142 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Background: Isometric resistance exercises (IREs) have great potential to improve blood pressure (BP) control. However, the effectiveness of IREs in reducing HT is still unknown because their hypotensive effects have not been detected using ambulatory BP measurements (ABPM), which are the current standard for BP measurement. Methods: This first adequately-powered RCT will involve 390 patients with HT who do not meet the current physical activity guidelines defined by the World Health Organization. Participants will be randomly assigned in a 1:1 ratio using stratified and blocked randomization to either the IRE (wall squat) group or stretching exercise (active control) group. A well-structured, widely accepted, and validated 24-week wall squat program (2 minutes per exercise, 2 minutes of rest between sets, and 3 sessions per week) will be implemented, as it has been commonly used in previous research. Adherence to the program will be monitored using smartwatches, and regular contact with patients through social media will help ensure adherence. All patients will be followed up for 1 year to investigate the long-term effects of IREs on BP. Control group will receive exact same treatment except that IRE is replaced by frequency-matched and time-matched stretching exercise. The primary outcome measure will be systolic daytime ABPM BP at 24 weeks. Secondary outcome measures will include other BP and ABPM parameters at 12 weeks, 24weeks and 1year, cfPWV at baseline, 24 weeks and 1year, and FMD at baseline and 24weeks. Safety data will be collected and reported.

CONDITIONS

Official Title

Isometric Resistance Exercise for Hypertension

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • A suboptimal daytime systolic blood pressure of >135-160 mmHg on a 24-hour ambulatory blood pressure monitoring
  • No regular physical activity or less than 150 minutes of moderate-intensity aerobic exercise per week
  • Stable doses of anti-hypertension medication for at least 4 weeks if receiving drug treatment
  • Agreement to no changes in blood pressure medications during the 24-week intervention period
Not Eligible

You will not qualify if you...

  • Unable or unwilling to provide informed consent
  • Unwillingness to repeat ambulatory blood pressure monitoring
  • Relative contraindications to ambulatory blood pressure monitoring such as diagnosed atrial fibrillation, nighttime workers, occupational drivers, or bleeding tendencies
  • Severe osteoarthritis pending knee replacement surgery
  • Known secondary hypertension
  • Use of 3 or more anti-hypertension medications at maximum doses or 4 or more anti-hypertension medications
  • Systolic blood pressure >160 mmHg or diastolic blood pressure >100 mmHg on ambulatory monitoring at baseline or 12 weeks
  • Pregnancy or breastfeeding
  • Active malignancy

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 2 locations

1

Lek Yuen General Outpatient Clinic

Hong Kong, Hong Kong, 00000

Actively Recruiting

2

School of public health and primary care

Hong Kong, Hong Kong

Actively Recruiting

Loading map...

Research Team

E

Eric Kam-Pui Lee, MSc, FRACGP

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

DOUBLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here